Publications by authors named "Gordon J Rustin"

Claim this Profile
A
A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma.
Jonathan Shamash, Rizwan Syed, Shah-Jalal Sarker, Naveed Sarwar, Anand Sharma, Gordon J Rustin

Eur J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologicals in the upfront treatment of ovarian cancer: focus on bevacizumab and poly (adp-ribose) polymerase inhibitors.
Rene Roux, Martin Zweifel, Gordon J S Rustin

Am Soc Clin Oncol Educ Book· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors.
Chooi Peng Lee, N Jane Taylor, Gerhardt Attard, Simon Pacey, Paul D Nathan, Gordon J Rustin

Oncologist· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer.
Marcia R Hall, Ann Petruckevitch, Joanna Pascoe, Mojca Persic, Saad Tahir, Gordon J Rustin

Int J Gynecol Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of surveillance following treatment of ovarian cancer.
Gordon J S Rustin

Gynecol Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current controversies in the management of germ cell ovarian tumours.
Ignacio Vazquez, Gordon J S Rustin

Curr Opin Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours.
Rowan E Miller, Tim Dudderidge, Robert Huddart, Michael J Seckl, Gordon J S Rustin

BJU Int· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
Paul Nathan, Martin Zweifel, Anwar R Padhani, Dow-Mu Koh, Matthew Ng, Gordon J S Rustin

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.
Dan M Patterson, Martin Zweifel, Mark R Middleton, Patricia M Price, Lisa K Folkes, Gordon J S Rustin

Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
R Timothy D Oliver, Graham M Mead, Gordon J S Rustin, Johnathan K Joffe, Nina Aass

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).
Gordon John Sampson Rustin, Ignace Vergote, Elizabeth Eisenhauer, Eric Pujade-Lauraine, Michael Quinn

Int J Gynecol Cancer· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.
Jonathan A Ledermann, Hani Gabra, Gordon C Jayson, Victoria J Spanswick, Gordon J S Rustin

Clin Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Gordon J S Rustin, Maria E L van der Burg, Clare L Griffin, David Guthrie, Alan Lamont

Lancet· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What surveillance plan should be advised for patients in remission after completion of first-line therapy for advanced ovarian cancer?
Gordon J S Rustin

Int J Gynecol Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to follow-up patients with epithelial ovarian cancer.
Rowan E Miller, Gordon J S Rustin

Curr Opin Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.
Roshan Agarwal, Charlie Gourley, Timothy J Perren, Nicholas Reed, David E Parkin, Gordon J S Rustin

Eur J Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas.
Tim Meyer, Andrew M Gaya, Gairin Dancey, Michael R L Stratford, Shokri Othman, Gordon J Rustin

Clin Cancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.
Anwar R Padhani, Guoying Liu, Dow Mu Koh, Thomas L Chenevert, Harriet C Thoeny, Gordon J S Rustin

Neoplasia· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
Robert C Bast, J Tate Thigpen, Susan G Arbuck, Karen Basen-Engquist, Laurie B Burke, Gordon J Rustin

Gynecol Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations.
Tyronne I Goonewardene, Marcia R Hall, Gordon J S Rustin

Lancet Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Robert A Huddart, Michael J O'Doherty, Anwar Padhani, Gordon J S Rustin, Graham M Mead

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors.
Katharine J Lankester, Jane N Taylor, James J Stirling, Jane Boxall, James A d'Arcy, Gordon J S Rustin

J Magn Reson Imaging· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.
Gordon J Rustin, Graham M Mead, Sally P Stenning, Paul A Vasey, Nina Aass

J Clin Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
Nirupa Murugaesu, Peter Schmid, Gairin Dancey, Roshan Agarwal, Lydia Holden, Gordon J S Rustin

J Clin Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in the management of germ cell tumours of the ovary.
Daniel M Patterson, Gordon J S Rustin

Curr Opin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis